Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
Despite the increase in the global prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD), no approved drug currently exists for the disease. Poria cocos (Schw.) Wolf (P. cocos) is a medicinal mushroom belonging to a family of polyporaceae widely used in TCM clinics to protect th...
Saved in:
Main Authors: | Jinbiao He (Author), Yu Yang (Author), Fan Zhang (Author), Yanjuan Li (Author), Xiaosi Li (Author), Xuemei Pu (Author), Xudong He (Author), Mei Zhang (Author), Xinxing Yang (Author), Qiuman Yu (Author), Yan Qi (Author), Xuefang Li (Author), Jie Yu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARα-SREBPs pathway
by: Jinbiao He, et al.
Published: (2023) -
Study of Herbs Cortex Moutan, Poria cocos, and Alisma orientale and Periodontitis
by: Xinyuan Hu, et al.
Published: (2024) -
Integrated Analysis and Finding Reveal Anti-Liver Cancer Targets and Mechanisms of Pachyman (Poria cocos Polysaccharides)
by: Li Qin, et al.
Published: (2021) -
Polysaccharide PCP-I isolated from Poria cocos enhances the immunogenicity and protection of an anthrax protective antigen-based vaccine
by: Kun Liu, et al.
Published: (2020) -
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
by: Jieyi Wang, et al.
Published: (2022)